BridgeBio Pharma, Inc. (BBIO) Discusses Positive FORTIFY Phase III Interim Results in Limb-Girdle Muscular Dystrophy Type 2I/R9 Transcript
ObservePlay Earnings NamePlay Earnings Name BridgeBio Pharma, Inc. (NASDAQ:BBIO) Discusses Constructive FORTIFY Part III Interim Leads to Limb-Girdle Muscular Dystrophy...







:max_bytes(150000):strip_icc()/Health-GettyImages-1145476673-846006383840410b94bd5712ce4cb06a.jpg)
